Establish Targeted Radiopharmaceuticals as the Next Pillar of Oncology Drugs Through Innovating Novel Design Approaches, Showcasing Emerging Clinical Data, & Streamlining Isotope Supply & Distribution
Radioligand therapy is evolving rapidly. With new targets like HER2 and FAP coming into focus, and promising data emerging beyond PSMA and SSTR2, there’s real momentum building in the field. But to fully unlock the potential of these therapies across Europe, and to integrate RLT as the next pillar of oncology treatment, we need more than scientific innovation. We need collaboration and harmonisation across the entire development journey.
The 7th Targeted Radiopharmaceuticals Summit Europe is here to make that happen.
This is the go-to meeting for anyone working to bring the next generation of targeted radiopharmaceuticals to patients, whether you’re involved in early discovery, clinical development, manufacturing, or regulatory affairs. Designed with input from leaders across the RLT space, this year’s summit is packed with practical insights, honest conversations, and real-world solutions.
“I thoroughly enjoyed the panel of experts, as their insights during the workshop and the summit were truly enriching. The quality of the talks was exceptional, and the summit's format fostered meaningful connections and engaging discussions with fellow attendees.”
Co-Founder & Chief Executive Officer, Aken Medical
“Excellent balance of interesting program content and ample time for networking.”
Chief Scientific Officer & Vice President, Research, Affibody AB
“Great and broad content. The smaller format enabling easy networking and meeting "all".”
Senior Director, Targeted Radiopharmaceuticals, Bayer
Explore the Full Event Guide
- 250+ Attendees from Biopharma
- 40+ World-Class Speakers
- 12+ C-Level Speakers
- 6 Pre-Conference Day Sessions
- 3 Dedicated Tracks of Content
Official Partners
Program Partner
Innovation Partners
Exhibition Partners
Attending Companies Include
Explore the Agenda
Explore the latest industry breakthroughs and get exclusive insights into radiopharmaceutical innovations with our expanded three-track agenda, covering discovery, preclinical research, translational science, clinical progress, CMC, and supply chain strategies.
Partner With Us
Align yourself with other leading solution providers to ensure your brand remains central to key biopharma deals and decision-making.
Join Biopharma Experts
Join the most important conversations with like-minded professionals across all stages of drug development, and build critical connections during dedicated networking sessions designed to foster collaboration and harmonisation throughout the entire development journey.